Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?
Fraile M, Gubern JM, Rull M, Julián FJ, Serra C, Llatjós M, Culell P, Puig P, Solà M, Vallejos V, Mariscal A, Janer J, Deulofeu P, Fusté F.
Fraile M, et al.
Nucl Med Commun. 2006 Oct;27(10):785-9. doi: 10.1097/01.mnm.0000230074.39071.bf.
Nucl Med Commun. 2006.
PMID: 16969260